A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants

Trial Identifier: D9230C00001
Start Date:December 2021
Primary Completion Date: November 2022
Study Completion Date: November 2022
Condition: Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

US, CA Glendale, CA, US, 91206